• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

International Implications Of Red Cross Trademark Fight Unclear

20/12/2007 by Catherine Saez, Intellectual Property Watch Leave a Comment

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

By Catherine Saez
Months after health products manufacturer Johnson & Johnson filed a civil complaint against the American Red Cross and its commercial licensees to stop using the symbol of a red cross, the public interest it generated seems to have all but subsided. However, questions about the possible consequences of this lawsuit at the international level remain unanswered.

After roughly 100 years of sharing the symbol, the two entities are now fighting over it. The lawsuit filed by US-based Johnson & Johnson (J&J) against the American Red Cross (ARC) and four of its licensing partners on 8 August focused mainly on preventing the ARC and its licensing partners from using the red cross design on commercial products such as first aid kits to prevent unfair competition. The American Red Cross has licensed sale of its kits in large-scale retailers such as Wal-Mart, Target and major drug stores.

In the lawsuit, J&J alleges that it began using the red cross in 1887, predating the formal recognition of the American Red Cross in 1900. But the ARC says it began using the red cross emblem at its foundation in 1881, six years before J&J.

In its first complaint, J&J demanded the seizure and destruction of all commercial items. But according to the ARC, on 6 September 2007, J&J filed an amended complaint cancelling that demand.

On 20 September, the ARC launched a legal response to J&J lawsuit, filing counterclaims that accuse the for-profit pharmaceutical company of improperly using the red cross emblem.

The ARC asserts that although the US Congress “grandfathered” J&J’s use of the red cross symbol – placing very specific, narrow restrictions on what the company could do – J&J is today using the red cross emblem beyond their “grandfathered” rights.

The ARC also claims that its first-aid and preparedness kits are designed to answer a public safety issue documented by research that show that “only 7 percent of Americans have taken the necessary steps to prepare for disasters, but 82 percent would get prepared if it was easier to do so.”

Could Fight Spread Beyond US Borders?

The 186 Red Cross national societies are independent and operate under national laws. However, in a globalised world, the question of J&J claiming the “exclusive use of the symbol of a red cross as a trademark” conceivably could apply elsewhere should J&J use the red cross on products sold outside of the United States. Company spokesperson Marc Monseau downplayed this possibility, saying, “This is a US legal matter concerning the American Red Cross.”

However, it is unclear whether J&J or any other entity with rights over the symbol could duplicate the claim in other countries. The United Kingdom Red Cross and the Australian Red Cross, for instance, appear to be commercialising first aid kits using the symbol.

According to the International Committee of the Red Cross, which addresses international humanitarian laws, the 1949 Geneva Convention protects the red cross emblem. Article 53 of the convention states: “The use by individuals, societies, firms or companies either public or private, other than those entitled thereto under the present convention, of the emblem or the designation ‘Red Cross’ or ‘Geneva Cross’ or any sign or designation constituting an imitation thereof, whatever the object of such use, and irrespective of the date of its adoption, shall be prohibited at all times.”

In “nearly all countries” the red cross emblem is protected by law and is the property of the governments, which then permit the use of the emblem by the Red Cross, according to the International Federation of Red Cross and Red Crescent (IFRC) in Geneva. According to the IFRC, there is no example of permission for private companies to use the emblem. In the United States, however the case is different; the protection is made by trademark. It is possible it could be interpreted that J&J could not use the red cross emblem anywhere other than the US market.

On 5 November, a federal judge dismissed one of the eight claims of the Johnson & Johnson lawsuit, according to an ARC press release.

It remains to be seen whether the fight will spread somehow outside US borders and invite other complaints over the use the red cross emblem.

Catherine Saez may be reached at csaez@ip-watch.ch.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Creative Commons License"International Implications Of Red Cross Trademark Fight Unclear" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: Features, Subscribers, Themes, English, Health & IP, IP Law, North America, Trademarks/Geographical Indications/Domains, United Nations - other

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.